New Markets Advi (508867)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Trades at only 1.10x book value (₹9.10 vs ₹8.26), so stated assets provide some support if they are real.
• Current price is at the bottom of the 52-week range, down from ₹22.85, so much negativity appears priced in.
• Small market cap of ₹5 crore creates the possibility of asymmetric upside if a genuine business is revived.
• ROCE, though low, is positive at 1.67%, suggesting some capital is still generating an operating return.

Concerns

• Latest quarter sales are ₹0 Cr and sales growth is -100%, meaning there is no active revenue-generating business.
• Profit growth of -211% and ROE of -6.45% indicate ongoing losses that can erode book value per share.
• Piotroski F-Score of 3/9 shows weak financial health across margins, leverage, and operating efficiency.
• No dividend, promoter holding not disclosed, and insufficient data make a reliable fundamental assessment impossible.

AI Analysis

At first glance, this is not a business I can value using earnings. New Markets Advi has zero sales in the latest quarter, sales growth of -100%, and profit growth of -211%. Graham would say the P/E is meaningless when the revenue line is empty. The only anchor is book value of ₹8.26 per share. At ₹9.10, the market cap is ₹5 crore, or 1.1 times book. That seems close to asset value, but an asset play demands a discount, not a premium, especially when the asset is not earning. ROE is -6.45%, so the company is destroying shareholder value. ROCE of 1.67% is no compensation when capital is idle and the F-score is a weak 3 out of 9. There is no dividend, promoter holding is not disclosed, and the available data is insufficient for any fair-stock conclusion. The shares trade at the low end of the 52-week range, down from ₹22.85, so disappointment is already in the price. Still, I need more than a low price. I need evidence that the book value is real, that management can deploy capital profitably, or that a genuine business exists. With zero sales, there is no moat, no pricing power, and no growth to analyse. This is a potential asset play, not a franchise. I would wait for the price to fall below book value, perhaps with a meaningful margin of safety, or for a credible plan to restart revenue. Until then, this is a stock to monitor from a distance, not one to own. In Buffett's language, 'turnaround' doesn't interest me unless the underlying business has a reason to improve. Here, I see none.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer